<?xml version="1.0" ?>
<GlossaryTerm id="CDR0000778737">
  <TermName>CEM regimen</TermName>
  <TermPronunciation>(… REH-jih-men)</TermPronunciation>
  <TermDefinition>
    <DefinitionText>An abbreviation for a chemotherapy combination used to treat high-risk neuroblastoma. It includes the drugs carboplatin, etoposide, and melphalan. Also called CEM.</DefinitionText>
    <Dictionary>Cancer.gov</Dictionary>
    <Audience>Patient</Audience>
  </TermDefinition>
  <MediaLink ref="CDR0000780317" type="audio/mpeg" alt="Pronunciation of dictionary term &quot;CEM regimen&quot;" language="en" id="_3"/>
  <MediaLink ref="CDR0000780318" type="audio/mpeg" alt="Pronunciation of dictionary term &quot;régimen CEM&quot;" language="es" id="_4"/>
  <SpanishTermName>régimen CEM</SpanishTermName>
  <SpanishTermDefinition>
    <DefinitionText>Nombre de una quimioterapia combinada que se usa para tratar el neuroblastoma de riesgo alto. Incluye los medicamentos carboplatino, etopósido y melfalán. También se llama terapia CEM.</DefinitionText>
    <Dictionary>Cancer.gov</Dictionary>
    <Audience>Patient</Audience>
  </SpanishTermDefinition>
  <DateFirstPublished>2016-02-11</DateFirstPublished>
  <RelatedInformation>
    <RelatedDrugSummaryRef UseWith="en" href="CDR0000778641" url="/about-cancer/treatment/drugs/CEM">CEM</RelatedDrugSummaryRef>
  </RelatedInformation>
</GlossaryTerm>
